PruGen Pharmaceuticals competitors

Zippia score 3.6

Competitor Summary. See how PruGen Pharmaceuticals compares to its main competitors:

Takeda Pharmaceuticals U.S.A., Inc. has the most employees (30,481).

Work at PruGen Pharmaceuticals?

Share your experience

PruGen Pharmaceuticals vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
PruGen Pharmaceuticals	2006	3.6	Scottsdale, AZ	1	$670,000	42
Axcan Pharma US Inc	1991	4.2	Birmingham, AL	1	$470.4M	525
BridgeBio	2014	4.2	Palo Alto, CA	1	$221.9M	396
EIP Pharma	2014	3.9	Cambridge, MA	1	$1.5M	7
Keysource Medical	2016	3.5	Cincinnati, OH	1	$23.1M	7
Pernix Therapeutics Holdings	1996	3.8	Morristown, NJ	1	$146.1M	171
Brad Pharm	1985	4.3	Fairfield, NJ	1	$145.0M	300
Shionogi	1878	4.4	Florham Park, NJ	2	$50.0M	6,082
Wraser Pharmaceutical	2002	3.1	Ridgeland, MS	1	$4.3M	25
Avion Pharmaceuticals	2011	3.9	Alpharetta, GA	1	$11.0M	206
Quinnova Pharmaceuticals Including Sarms, Peptides and More	2003	3.4	Newtown, PA	1	$5.3M	75
Topix Pharmaceuticals	1981	3.5	Amityville, NY	1	$11.5M	150
Daiichi Sankyo	2005	4.8	Parsippany-Troy Hills, NJ	2	$9.0B	15,348
Takeda Pharmaceuticals U.S.A., Inc.	1998	4.7	Deerfield, IL	14	$12.1B	30,481
Aqua Pharmaceuticals	2004	4.3	West Chester, PA	1	$8.6M	71
Santarus	1996	4.5	San Diego, CA	1	$218.0M	290
Hill Dermaceuticals	-	3.9	Sanford, FL	1	$7.5M	46
Aytu BioPharma	2015	4.3	Englewood, CO	1	$27.6M	100
Xanodyne Pharmaceuticals	2000	4.3	Newport, KY	1	$18.8M	100
Odyssey Pharmaceuticals Inc	2000	3.7	East Hanover, NJ	1	$6.2M	9
Mission Pharmacal	1946	4.3	San Antonio, TX	2	$140.0M	750

Rate PruGen Pharmaceuticals' competitiveness in the market.

PruGen Pharmaceuticals salaries vs competitors

Compare PruGen Pharmaceuticals salaries vs competitors

Company	Average salary	Hourly salary	Salary score
PruGen Pharmaceuticals	$67,850	$32.62	-

Compare PruGen Pharmaceuticals job title salaries vs competitors

Company	Highest salary	Hourly salary
PruGen Pharmaceuticals	$72,717	$34.96
Takeda Pharmaceuticals U.S.A., Inc.	$77,428	$37.23
Axcan Pharma US Inc	$76,793	$36.92
Avion Pharmaceuticals	$76,104	$36.59
Daiichi Sankyo	$75,293	$36.20
Wraser Pharmaceutical	$74,554	$35.84
Santarus	$74,381	$35.76
BridgeBio	$74,274	$35.71
Aqua Pharmaceuticals	$73,824	$35.49
Shionogi	$73,350	$35.26
Pernix Therapeutics Holdings	$73,345	$35.26
Xanodyne Pharmaceuticals	$73,037	$35.11
Hill Dermaceuticals	$72,920	$35.06
Mission Pharmacal	$72,806	$35.00
Odyssey Pharmaceuticals Inc	$72,586	$34.90
Quinnova Pharmaceuticals Including Sarms, Peptides and More	$72,503	$34.86
Keysource Medical	$72,296	$34.76
Brad Pharm	$72,231	$34.73
Topix Pharmaceuticals	$72,166	$34.70
Aytu BioPharma	$71,882	$34.56

Do you work at PruGen Pharmaceuticals?

Does PruGen Pharmaceuticals effectively differentiate itself from competitors?

PruGen Pharmaceuticals jobs

PruGen Pharmaceuticals demographics vs competitors

Compare gender at PruGen Pharmaceuticals vs competitors

Job title	Male	Female
Shionogi	45%	55%
Takeda Pharmaceuticals U.S.A., Inc.	49%	51%
Daiichi Sankyo	51%	49%
Avion Pharmaceuticals	52%	48%
Wraser Pharmaceutical	60%	40%
PruGen Pharmaceuticals	-	-

Male

Female

100%

75%

50%

25%

PruGen Pharmaceuticals

Wraser Pharmaceutical

Avion Pharmaceuticals

Daiichi Sankyo

Takeda Pharmaceuticals U.S.A., Inc.

Shionogi

25%

50%

75%

100%

Compare race at PruGen Pharmaceuticals vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Daiichi Sankyo	60%	15%	11%	10%	4%	9.5
Shionogi	61%	14%	14%	8%	4%	9.7
Takeda Pharmaceuticals U.S.A., Inc.	61%	13%	11%	12%	4%	9.7
Wraser Pharmaceutical	60%	12%	20%	5%	2%	6.8
Avion Pharmaceuticals	58%	17%	15%	8%	3%	6.8

PruGen Pharmaceuticals and similar companies CEOs

CEOBio

John A. Sedor

Pernix Therapeutics Holdings

An intuitive leader who engenders a deep level of trust and loyalty while providing a clear vision and business strategy, with a proven track record in the pharmaceutical, generic, biotechnology and consumer product industries. Recognized for entrepreneurial leadership approach to turnaround and rapid growth environments, leveraging strategic creativity, consumer and professional customer insight, merger and acquisition experience and operational expertise, all driving shareholder value. Open to contract C-level and Board of Director positions.

John Fraher

Axcan Pharma US Inc

John Fraher is a Chief Executive Officer at Aptalis Pharma Inc, Chief Executive Officer at Eurand NV, and Board Member at Ellodi Pharmaceuticals and is based in United States. He has worked as Pres:Aptalis Pharma Technologies at Aptalis Pharma Inc, Production Manager at Fort Dodge Animal Health, and President at Aptalis Pharma Inc. John works or has worked as President:America at Eurand Pharmaceuticals Hldg. He attended University College Dublin between 1984 and 1989.

Ken Keller

Daiichi Sankyo

Neill “Gobie” Walsdorf

Mission Pharmacal

Gary D. Glick

Odyssey Pharmaceuticals Inc

Nathan McCutcheon

Shionogi

Daniel Glassman

Brad Pharm

Heath Wray

Wraser Pharmaceutical

Jeffrey S. Day

Quinnova Pharmaceuticals Including Sarms, Peptides and More

Joshua R. Disbrow

Aytu BioPharma